Skip to main content
Posttraumatic Stress DisorderPTSD and traumaMental healthFirst-in-humanDevicePhase 2

What this study is

The goal of this study is to develop a new, non-invasive brain stimulation modality called low intensity focused ultrasound (FUS) as a psychiatric rehabilitation treatment for posttraumatic stress disorder (PTSD). FUS delivers energy comparable to that involved in diagnostic ultrasound but in a millimeter-sized envelope. Unlike currently available methods, the maximal FUS energy is delivered at a distance from a transducer on the scalp. Therefore, its promise is that it can deliver focal and reversible modulation to deeper brain regions involved in PTSD. The investigator team has previously conducted first-in-human research in FUS, and this study builds upon that work to conduct a phase II, dose-finding study. This study will pursue two Aims; the first is whether FUS to the amygdala can improve symptoms, and the second will evaluate whether FUS improves function by reduced disability, over a 1-month period. Short and longer-term effects of FUS will be measured and all FUS parameters are within FDA-defined safety thresholds for diagnostic ultrasound.

What's being tested

  • Brainsonix Ultrasound Device

    Intervention · DEVICE

    This device delivers low intensity focused ultrasound and delivers either active or sham sonication depending upon the transducer pad used.

Study details

Official title
Low Intensity Focused Ultrasound for Posttraumatic Stress Disorder
Sponsor
VA Office of Research and Development
Conditions
Posttraumatic Stress Disorder
Enrolling
60 people
Starts
2026-09-09
Est. completion
2030-03-29
Design
Triple-blind, randomized, parallel groups, Phase 2
Record
View on ClinicalTrials.gov ↗